États-Unis - anglais - NLM (National Library of Medicine)

bryant ranch prepack - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride/sotalol hydrochloride af tablets are indicated for the treatment of documented, life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia (vt). limitation of use: sotalol hydrochloride/sotalol hydrochloride af has not been shown to enhance survival in patients with life-threatening ventricular arrhythmias. sotalol hydrochloride/sotalol hydrochloride af tablets are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of afib/afl) in patients with highly symptomatic afib/afl who are currently in sinus rhythm. limitation of use: because sotalol hydrochloride/sotalol hydrochloride af tablets can cause life-threatening ventricular arrhythmias, reserve its use for patients in whom afib/afl is highly symptomatic. patients with paroxysmal afib that is easily reversed (by valsalva maneuver, for example) should usually not be given sotalol hydrochloride/sotalol hydrochloride af tablets. sotalol hydrochloride/sotalol hydrochloride (af) tablets

États-Unis - anglais - NLM (National Library of Medicine)

bryant ranch prepack - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride tablets are indicated for the treatment of documented, life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia (vt). limitation of use sotalol hydrochloride tablets have not been shown to enhance survival in patients with life-threatening ventricular arrhythmias. sotalol hydrochloride tablets are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of afib/afl) in patients with highly symptomatic afib/afl who are currently in sinus rhythm. limitation of use: because sotalol hydrochloride tablets can cause life-threatening ventricular arrhythmias, reserve its use for patients in whom afib/afl is highly symptomatic. patients with paroxysmal afib that is easily reversed (by valsalva maneuver, for example) should usually not be given sotalol hydrochloride tablets. sotalol hydrochloride tablets are contraindicated in patients with: - sinus bradycardia, sick sinus syndrome, second and third degree av block, unless a functioning pac

États-Unis - anglais - NLM (National Library of Medicine)

bryant ranch prepack - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride tablets are indicated for the treatment of documented, life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia (vt). limitation of use: sotalol hydrochloride tablets have not been shown to enhance survival in patients with life-threatening ventricular arrhythmias. sotalol hydrochloride tablets are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of afib/afl) in patients with highly symptomatic afib/afl who are currently in sinus rhythm. limitation of use: because sotalol hydrochloride tablets can cause life-threatening ventricular arrhythmias, reserve its use for patients in whom afib/afl is highly symptomatic. patients with paroxysmal afib that is easily reversed (by valsalva maneuver, for example) should usually not be given sotalol hydrochloride tablets. sotalol hydrochloride tablets are contraindicated in patients with: - sinus bradycardia, sick sinus syndrome, second and third degree av block, unless a functioning pacemake

États-Unis - anglais - NLM (National Library of Medicine)

marlex pharmaceuticals inc - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride tablets are indicated for the treatment of life-threatening, documented ventricular arrhythmias, such as sustained ventricular tachycardia (vt). limitation of use: sotalol hydrochloride tablets may not enhance survival in patients with ventricular arrhythmias. because of the proarrhythmic effects of sotalol hydrochloride tablets, including a 1.5 to 2% rate of torsade de pointes (tdp) or new ventricular tachycardia/fibrillation (vt/vf) in patients with either non-sustained ventricular tachycardia (nsvt) or supraventricular arrhythmias (svt), its use in patients with less severe arrhythmias, even if the patients are symptomatic, is generally not recommended. avoid treatment of patients with asymptomatic ventricular premature contractions [ see   warnings   and precautions ( 5.2 ) .] sotalol hydrochloride tablets are contraindicated in patients with: - sinus bradycardia, sick sinus syndrome, second and third degree av block, unless a functioning pacemaker is present - congenit

États-Unis - anglais - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride tablets are indicated for the treatment of life-threatening, documented ventricular arrhythmias, such as sustained ventricular tachycardia (vt). limitation of use: sotalol hydrochloride tablets may not enhance survival in patients with ventricular arrhythmias. because of the proarrhythmic effects of sotalol hydrochloride tablets, including a 1.5 to 2% rate of torsade de pointes (tdp) or new ventricular tachycardia/fibrillation (vt/vf) in patients with either non-sustained ventricular tachycardia (nsvt) or supraventricular arrhythmias (svt), its use in patients with less severe arrhythmias, even if the patients are symptomatic, is generally not recommended. avoid treatment of patients with asymptomatic ventricular premature contractions [see   warnings   and precautions ( 5.2 ) .] sotalol hydrochloride tablets are contraindicated in patients with: - sinus bradycardia, sick sinus syndrome, second and third degree av block, unless a functioning pacemaker is present - congenital or acquired

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

viatris limited - sotalol hydrochloride 160mg - tablet - 160 mg - active: sotalol hydrochloride 160mg excipient: calcium hydrogen phosphate magnesium stearate maize starch povidone purified talc sodium starch glycolate - sotalol hydrochloride is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

viatris limited - sotalol hydrochloride 80mg - tablet - 80 mg - active: sotalol hydrochloride 80mg excipient: calcium hydrogen phosphate magnesium stearate maize starch povidone purified talc sodium starch glycolate - sotalol hydrochloride is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: magnesium stearate; stearic acid; indigo carmine; maize starch; colloidal anhydrous silica; microcrystalline cellulose; lactose - sotalol-str is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - sotalol hydrochloride, quantity: 80 mg - tablet, uncoated - excipient ingredients: lactose; microcrystalline cellulose; indigo carmine; maize starch; colloidal anhydrous silica; magnesium stearate; stearic acid - sotalol-str is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: magnesium stearate; stearic acid; indigo carmine; maize starch; colloidal anhydrous silica; microcrystalline cellulose; lactose - sotalol-arx is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.